Central Nervous System (CNS) Therapeutics Market Report by 2033
The treatment landscape is diverse, employing various strategies, including pharmacological interventions, surgical procedures, and emerging therapies like gene therapy. Medications may involve antidepressants, antipsychotics, or other drugs specifically aimed at targeting neural pathways. Ongoing research in this field is continually evolving, fueled by advancements in neuroscience and biotechnology.
Read More: https://www.imarcgroup.com...
The treatment landscape is diverse, employing various strategies, including pharmacological interventions, surgical procedures, and emerging therapies like gene therapy. Medications may involve antidepressants, antipsychotics, or other drugs specifically aimed at targeting neural pathways. Ongoing research in this field is continually evolving, fueled by advancements in neuroscience and biotechnology.
Read More: https://www.imarcgroup.com...
Central Nervous System (CNS) Therapeutics Market | 2033
The global central nervous system (CNS) therapeutics market size reached USD 148.7 Billion in 2024 and grow at a CAGR of 5.64% to reach USD 257.3 Billion by 2033.
https://www.imarcgroup.com/central-nervous-system-therapeutics-market
17 days ago